Aminosalicylates

It is recommended that patients receiving aminosalicylates should be advised to report any unexplained bleeding, bruising, purpura, sore throat, fever, or malaise that occurs during treatment. A blood count should be performed and the drug stopped immediately if there is suspicion of a blood dyscrasia.

There is no evidence to show that any one oral preparation of mesalazine is more effective than another, however, the delivery characteristics of oral mesalazine preparations may vary. If it is necessary to switch a patient to a different brand of mesalazine, the patient should be advised to report any changes in symptoms.

There is no evidence to show that any one oral preparation of mesalazine is more effective than another, however, the delivery characteristics of oral mesalazine preparations may vary.

If it is necessary to switch a patient to a different brand of mesalazine, the patient should be advised to report any changes in symptoms.

Pack
100 tablet
50 tablet
Pack
60 tablet
Pack
90 tablet
120 tablet
84 tablet
168 tablet
60 tablet
Pack
100 tablet
Pack
180 tablet
90 tablet
84 tablet
Pack
90 tablet
60 tablet
Pack
60 tablet
120 tablet
Pack
50 sachet
Pack
60 sachet
Pack
60 sachet
Pack
60 sachet
Pack
10 suppository
30 suppository
20 suppository
Pack
28 suppository
10 suppository
30 suppository
Pack
14 actuation
Pack
7 enema
Pack
7 enema
Pack
130 capsule
112 capsule
Pack
100 tablet
112 tablet
50 tablet
500 tablet
Pack
100 tablet
112 tablet
56 tablet

Restricted for patients with swallowing difficulties.

Pack
500 ml
Pack
10 suppository
  • On Formulary Preferred
  • On Formulary Second Line
  • On Formulary Third Line
  • Specialist Initiation
  • Secondary Care Only
  • Not Approved for Formulary